A public-private partnership between ARPA-H and VentureWell in support of the ARPANET-H nationwide health innovation network. Website is maintained by VentureWell staff.
CATALYST Information Session
November 12 @ 3:30 pm – 4:30 pm EST
The Advanced Research Projects Agency for Health (ARPA-H) recently launched the Computational ADME-Tox and Physiology Analysis for Safer Therapeutics (CATALYST) program which aims to revolutionize preclinical drug safety prediction by developing human-based models that accurately estimate toxicity and safety profiles for drug candidates.
ARPA-H Program Manager Andy Kilianski, Ph.D., will host this information session and provide potential performers with an overview of CATALYST, the goals of the program, technical areas of focus, and upcoming deadlines. There will be time for Q&A.